Companies House 16034984 2025-10-31 2025-10-31 2024-10-22 false iso4217:GBP xbrli:pure 16034984 2025-10-31 16034984 2024-10-22 2025-10-31 16034984 curr:PoundSterling 2024-10-22 2025-10-31 16034984 uk-bus:CompanyLimitedByGuarantee 2024-10-22 2025-10-31 16034984 uk-bus:FRS102 2024-10-22 2025-10-31 16034984 uk-bus:AuditExempt-NoAccountantsReport 2024-10-22 2025-10-31 16034984 uk-bus:FullAccounts 2024-10-22 2025-10-31 16034984 uk-bus:RegisteredOffice 2024-10-22 2025-10-31 16034984 uk-bus:Director1 2024-10-22 2025-10-31 16034984 uk-bus:Director2 2024-10-22 2025-10-31 16034984 uk-bus:Director3 2024-10-22 2025-10-31 16034984 uk-bus:Director4 2024-10-22 2025-10-31 16034984 uk-bus:Director5 2024-10-22 2025-10-31 16034984 uk-bus:Director6 2024-10-22 2025-10-31 16034984 uk-bus:Director7 2024-10-22 2025-10-31 16034984 uk-bus:Director8 2024-10-22 2025-10-31 16034984 uk-bus:Director9 2024-10-22 2025-10-31 16034984 uk-bus:Director10 2024-10-22 2025-10-31 16034984 uk-bus:Director11 2024-10-22 2025-10-31 16034984 uk-bus:Director12 2024-10-22 2025-10-31 16034984 uk-bus:Director13 2024-10-22 2025-10-31 16034984 uk-bus:Director14 2024-10-22 2025-10-31 16034984 uk-bus:Director15 2024-10-22 2025-10-31 16034984 uk-bus:Director16 2024-10-22 2025-10-31 16034984 uk-bus:Director17 2024-10-22 2025-10-31 16034984 uk-bus:Director18 2024-10-22 2025-10-31 16034984 uk-bus:Director19 2024-10-22 2025-10-31 16034984 uk-bus:Director20 2024-10-22 2025-10-31 16034984 uk-bus:Director21 2024-10-22 2025-10-31 16034984 uk-bus:CompanySecretary1 2024-10-22 2025-10-31 16034984 core:AfterOneYear 2025-10-31 16034984 core:WithinOneYear 2025-10-31 16034984 core:WithinOneYear 2024-10-22 2025-10-31 16034984 core:AfterOneYear 2025-10-31 16034984 core:AfterOneYear 2024-10-22 2025-10-31 16034984 core:ShareCapital 2025-10-31 16034984 core:SharePremium 2025-10-31 16034984 core:OtherReservesSubtotal 2025-10-31 16034984 core:RevaluationReserve 2025-10-31 16034984 core:RetainedEarningsAccumulatedLosses 2025-10-31 16034984 1 2024-10-22 2025-10-31 16034984 2 2024-10-22 2025-10-31 16034984 3 2024-10-22 2025-10-31 16034984 core:LandBuildings 2024-10-22 2025-10-31 16034984 core:LandBuildings 2025-10-31 16034984 core:PlantMachinery 2024-10-22 2025-10-31 16034984 core:PlantMachinery 2025-10-31 16034984 core:FurnitureFittingsToolsEquipment 2024-10-22 2025-10-31 16034984 core:FurnitureFittingsToolsEquipment 2025-10-31 16034984 core:OfficeEquipment 2024-10-22 2025-10-31 16034984 core:OfficeEquipment 2025-10-31 16034984 core:Vehicles 2024-10-22 2025-10-31 16034984 core:Vehicles 2025-10-31 16034984 core:NetGoodwill 2024-10-22 2025-10-31 16034984 core:NetGoodwill 2025-10-31 16034984 core:IntangibleAssetsOtherThanGoodwill 2024-10-22 2025-10-31 16034984 core:IntangibleAssetsOtherThanGoodwill 2025-10-31

# SISU THERAPEUTIC SERVICES C.I.C.

## Company limited by guarantee

## Company Registration Number:
16034984 (England and Wales)

## Unaudited statutory accounts for the year ended 31 October 2025

## Period of accounts

## Start date: 22 October 2024

## End date: 31 October 2025

# SISU THERAPEUTIC SERVICES C.I.C.

## Contents of the Financial Statements

for the Period Ended 31 October 2025

Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# SISU THERAPEUTIC SERVICES C.I.C.

## Profit And Loss Account

for the Period Ended 31 October 2025

| 2025
--- | ---
| £
Turnover: | 31,380 |
Cost of sales: | ( 6,235 ) |
Gross profit(or loss): | 25,145
Administrative expenses: | ( 34,361 ) |
Other operating income: | 6,120 |
Operating profit(or loss): | (3,096)
Profit(or loss) before tax: | (3,096)
Profit(or loss) for the financial year: | (3,096)

# SISU THERAPEUTIC SERVICES C.I.C.

## Balance sheet

As at 31 October 2025

| Notes | 2025
--- | --- | ---
|  | £
Fixed assets
Tangible assets: | 3 | 569 |
Total fixed assets: |  | 569
Current assets
Debtors: | 4 | 452 |
Total current assets: |  | 452
Net current assets (liabilities): |  | 452
Total assets less current liabilities: |  | 1,021
Creditors: amounts falling due after more than one year: | 5 | ( 4,117 ) |
Total net assets (liabilities): |  | (3,096)
Members' funds
Profit and loss account: |  | (3,096) |
Total members' funds: |  | ( 3,096)

The notes form part of these financial statements

# SISU THERAPEUTIC SERVICES C.I.C.

## Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 11 July 2026
and signed on behalf of the board by:

Name: Kimberley Fuller
Status: Director

The notes form part of these financial statements

# SISU THERAPEUTIC SERVICES C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 October 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

# SISU THERAPEUTIC SERVICES C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 October 2025

- ## 2. Employees

  | 2025
  --- | ---
  Average number of employees during the period | 0 |

# SISU THERAPEUTIC SERVICES C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
Additions |  |  |  | 569 |  | 569
Disposals |  |  |  |  |  |
Revaluations |  |  |  |  |  |
Transfers |  |  |  |  |  |
At 31 October 2025 |  |  |  | 569 |  | 569
Depreciation |  |  |  |  |  |
Charge for year |  |  |  |  |  |
On disposals |  |  |  |  |  |
Other adjustments |  |  |  |  |  |
At 31 October 2025 |  |  |  |  |  |
Net book value |  |  |  |  |  |
At 31 October 2025 |  |  |  | 569 |  | 569

# SISU THERAPEUTIC SERVICES C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 4. Debtors

| 2025
--- | ---
| £
Trade debtors | 452 |
Total | 452

# SISU THERAPEUTIC SERVICES C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 5. Creditors: amounts falling due after more than one year note

| 2025
--- | ---
| £
Other creditors | 4,117 |
Total | 4,117

# COMMUNITY INTEREST ANNUAL REPORT

### SISU THERAPEUTIC SERVICES C.I.C.

### Company Number: 16034984 (England and Wales)

### Year Ending: 31 October 2025

Company activities and impact

We provide a wide range of therapeutic options tailored to support community needs, including one-on-one therapy sessions such as counselling, talk therapy and psychotherapy. We also integrate creative approaches - Art, Music, Dance movement, Drama, and other modalities to ensure we address the evolving needs of individuals and communities alike. Our services also extend beyond individual therapy, we also offer family and parenting support. We offer specialised therapeutic training and bespoke programmes tailored to meet your organisation's unique needs. Our training addresses the challenges professionals face working with individuals with complex needs. By focusing on trauma-informed care and the intersectional factors that affect mental health, we aim to equip workers with practical strategies for creating more responsive and empathetic teams. Our bespoke mental health and well-being training provides organisations with the tools to recognise, understand and support mental health challenges within those accessing your services. This approach helps foster a compassionate, inclusive environment that prioritises the mental health and agency of individuals, ultimately improving outcomes and creating a culture of support and resilience within your organisation.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
11 July 2026

And signed on behalf of the board by:
Name: Kimberley Fuller
Status: Director